Physician profile
Tai H Pham
NPI 1447649769
$89,435.18
in general payments reported to CMS, 2019-2025
27 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $884 · 2021: $3,457 · 2022: $12K · 2023: $47K · 2024: $11K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $40K · Food and Beverage: $17K · Travel and Lodging: $8,754 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,250 · Consulting Fee: $1,100 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $39,600.00 |
| Food and Beverage | $16,983.05 |
| Travel and Lodging | $8,753.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,250.00 |
| Consulting Fee | $1,100.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $33,327.31 | 2019-2025 | Versacross Access Solution, Watchman Flx, General - Therapies |
| Abbott Laboratories | $20,157.30 | 2019-2025 | Mitraclip, Triclip, Amplatzer Amulet |
| Medtronic, INC. | $16,030.55 | 2021-2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $3,303.74 | 2023-2025 | Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Philips North America LLC | $2,450.94 | 2021-2025 | (Bq9) Coronary Ivus, Coronary Other, (Br0) Coronary Atherectomy |
| Shockwave Medical, INC | $2,236.29 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,186.58 | 2019-2025 | Lifevest |
| Teleflex LLC | $1,745.86 | 2022-2025 | Guideliner, Turnpike, Orsiro Mission |
| Abiomed | $1,708.48 | 2021-2025 | Impella |
| Biotronik INC. | $1,574.22 | 2020-2024 | Orsiro Mission, Recross, Nhancer Rx |
| Cordis US Corp. | $1,264.49 | 2023-2025 | Emerald, Rain Sheath Transradial |
| Asahi Intecc USA, INC. | $746.13 | 2021-2024 | Peripheral Vascular, Asahi Ptca Guide Wire |
| Chiesi USA, INC. | $529.70 | 2020-2025 | Kengreal |
| W. L. Gore & Associates, INC. | $496.60 | 2024-2025 | Gore Cardioform Septal Occluder |
| Reflow Medical INC | $285.25 | 2024-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $272.34 | 2021-2022 | |
| Amgen INC. | $237.49 | 2022-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.17 | 2019-2021 | |
| Recor Medical INC | $139.36 | 2024 | Paradise Renal Denervation System |
| Novartis Pharmaceuticals Corporation | $137.75 | 2019 | |
| Janssen Pharmaceuticals, INC | $122.31 | 2021 | |
| Kestra Medical Technology Services, INC. | $116.88 | 2024 | Assure Wcd |
| Heartflow, INC. | $93.30 | 2021-2022 | |
| Cathworks, INC. | $60.15 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $36.36 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.94 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tai Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.